Eris Lifesciences Limited (NSE:ERIS)
India flag India · Delayed Price · Currency is INR
1,360.70
-9.50 (-0.69%)
At close: Mar 6, 2026

Eris Lifesciences Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
188,489192,990114,71977,80193,61582,147
Market Cap Growth
9.44%68.23%47.45%-16.89%13.96%64.00%
Enterprise Value
215,753221,970121,26880,08592,60080,183
Last Close Price
1360.701417.35838.59568.87677.58590.51
PE Ratio
43.0254.8529.2620.3623.0523.13
Forward PE
29.0738.8025.7917.1521.2321.38
PS Ratio
6.156.705.764.687.066.89
PB Ratio
5.385.903.563.504.915.21
P/TBV Ratio
----8.1010.28
P/FCF Ratio
-21.2132.15-36.3923.50
P/OCF Ratio
-18.1223.6026.6724.7521.89
PEG Ratio
0.961.291.611.911.461.14
EV/Sales Ratio
7.047.716.094.826.986.72
EV/EBITDA Ratio
17.6022.0918.3015.2319.1818.82
EV/EBIT Ratio
26.5431.5924.5318.9921.8120.69
EV/FCF Ratio
-24.3933.98-36.0022.94
Debt / Equity Ratio
0.680.760.860.400.050.01
Debt / EBITDA Ratio
1.952.444.131.660.190.04
Debt / FCF Ratio
-2.727.79-0.360.05
Net Debt / Equity Ratio
0.660.700.450.36-0.06-0.07
Net Debt / EBITDA Ratio
1.912.262.181.53-0.25-0.26
Net Debt / FCF Ratio
-2.504.04-1.47-0.46-0.32
Asset Turnover
-0.410.370.560.650.70
Inventory Turnover
-2.802.472.902.492.95
Quick Ratio
-0.560.751.221.991.78
Current Ratio
-0.890.911.733.142.80
Return on Equity (ROE)
-11.54%14.59%18.12%23.29%24.72%
Return on Assets (ROA)
-6.24%5.77%8.87%12.92%14.31%
Return on Invested Capital (ROIC)
10.80%10.55%11.84%16.19%23.95%26.52%
Return on Capital Employed (ROCE)
-12.40%11.00%13.10%20.50%23.20%
Earnings Yield
2.29%1.82%3.42%4.91%4.34%4.32%
FCF Yield
-4.71%3.11%-7.07%2.75%4.26%
Dividend Yield
0.54%0.52%-1.29%0.89%0.93%
Payout Ratio
-28.44%-26.14%20.10%21.03%
Buyback Yield / Dilution
-0.03%-0.09%-0.03%-0.19%-0.02%1.03%
Total Shareholder Return
0.51%0.43%-0.03%1.10%0.86%1.97%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.